Celia Foissac-Jacoberger
Brisbane, QLD 4006, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
NOD1 Agonist Induces Proliferation and Plasma Cell Differentiation of Mouse B Cells Especially CD23high B Cells.
Journal: Immunological investigations
Published: November 19, 2024
Assessing the Efficacy of Immune Checkpoint Inhibitors in Preclinical Tumor Models.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: December 31, 2022
Adenosine A2A receptor is a tumor suppressor of NASH-associated hepatocellular carcinoma.
Journal: Cell reports. Medicine
Published: December 01, 2022
Addition of interleukin-2 overcomes resistance to neoadjuvant CTLA4 and PD1 blockade in ex vivo patient tumors.
Journal: Science translational medicine
Published: April 27, 2022
CD73 Inhibits cGAS-STING and Cooperates with CD39 to Promote Pancreatic Cancer.
Journal: Cancer immunology research
Published: April 04, 2022
Concomitant or delayed anti-TNF differentially impact on immune-related adverse events and antitumor efficacy after anti-CD40 therapy.
Journal: Journal for immunotherapy of cancer
Published: October 16, 2020
Liposomes as tunable platform to decipher the antitumor immune response triggered by TLR and NLR agonists.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: December 20, 2019
Control of Metastases via Myeloid CD39 and NK Cell Effector Function.
Journal: Cancer immunology research
Published: October 04, 2019
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity.
Journal: Cancer discovery
Published: May 18, 2019
Optimization of peptide-based cancer vaccine compositions, by sequential screening, using versatile liposomal platform.
Journal: International journal of pharmaceutics
Published: January 04, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026